CVE:NXG NexgenRx (NXG) Stock Price, News & Analysis C$0.25 -0.03 (-10.71%) As of 04/2/2025 02:15 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesInsider TradesBuy This Stock About NexgenRx Stock (CVE:NXG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NexgenRx alerts:Sign Up Key Stats Today's RangeC$0.25▼C$0.2550-Day RangeC$0.25▼C$0.2852-Week RangeC$0.19▼C$0.35Volume1,500 shsAverage Volume48,651 shsMarket CapitalizationC$17.73 millionP/E RatioN/ADividend Yield4.00%Price TargetN/AConsensus RatingN/A Company OverviewNexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.Read More… Remove Ads Receive NXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. Email Address NXG Stock News HeadlinesNexgenRx Inc.: NexgenRx Announces Third Quarter Results and Declaration of DivdendNovember 26, 2024 | finanznachrichten.deCan NexgenRx Inc.'s (CVE:NXG) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?November 26, 2024 | uk.finance.yahoo.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 4, 2025 | Porter & Company (Ad)NexgenRx Announces Third Quarter Results and Declaration of DivdendNovember 26, 2024 | finance.yahoo.comNexgenRX Inc.September 19, 2024 | wsj.comClosing Bell: Nexgenrx Inc up on Monday (NXG)July 20, 2024 | theglobeandmail.comNexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record EarningsMay 17, 2024 | stockhouse.comNexgenRx Announces Annual Meeting ResultsMay 16, 2024 | stockhouse.comSee More Headlines NXG Stock Analysis - Frequently Asked Questions How have NXG shares performed this year? NexgenRx's stock was trading at C$0.28 at the start of the year. Since then, NXG stock has decreased by 9.1% and is now trading at C$0.25. View the best growth stocks for 2025 here. How do I buy shares of NexgenRx? Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of NexgenRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that NexgenRx investors own include WestJet Airlines (WJA), Vision Marine Technologies (VMAR), Hydro One (H) and Carvana (CVNA). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Healthcare Plans Sub-IndustryN/A Current SymbolCVE:NXG CIKN/A Webwww.nexgenrx.com Phone+1-416-6953393FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.06 million Net Margins-0.17% Pretax MarginN/A Return on Equity-0.31% Return on Assets0.42% Debt Debt-to-Equity Ratio6.16 Current Ratio1.08 Quick Ratio0.12 Sales & Book Value Annual SalesC$15.34 million Price / Sales1.16 Cash FlowC$0.03 per share Price / Cash Flow9.64 Book ValueC$0.09 per share Price / Book2.78Miscellaneous Outstanding Shares70,920,000Free FloatN/AMarket CapC$17.73 million OptionableNot Optionable Beta0.29 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (CVE:NXG) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.